Dr. Arvind Y. Krishna, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
4565 Dressler Rd Nw, Suite 111
Canton, OH 44718
Who else practices at this address →
Stark County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 42
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 787
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
OH license 35068403K · GA license 036553
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mercy Medical Center Canton, OH
- Aultman Hospital Canton, OH
- Alliance Community Hospital Alliance, OH
- Aultman Orrville Hospital Orrville, OH
- Pomerene Hospital Millersburg, OH
Medical groups
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 787
- Services billed
- 11,536
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,375 | 533 |
| Established patient office or other outpatient visit, 20-29 minutes | 390 | 229 |
| Hemoglobin a1c level | 165 | 121 |
| Injection of drug or substance under skin or into muscle | 132 | 14 |
| New patient office or other outpatient visit, 45-59 minutes | 71 | 71 |
| Ultrasound scan of head and neck soft tissue | 34 | 34 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 33 | 30 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 33 | 31 |
| New patient office or other outpatient visit, 60-74 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Canton, OH | 745 |
| Synthroid (levothyroxine sodium) Other prescribers in Canton, OH | 267 |
| Jardiance (empagliflozin) Other prescribers in Canton, OH | 218 |
| Metformin Hcl Other prescribers in Canton, OH | 205 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Canton, OH | 123 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Canton, OH | 94 |
| Trulicity (dulaglutide) Other prescribers in Canton, OH | 90 |
| Atorvastatin Calcium Other prescribers in Canton, OH | 88 |
| Methimazole Other prescribers in Canton, OH | 82 |
| Rosuvastatin Calcium Other prescribers in Canton, OH | 81 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 35 payments worth $656 in total to this clinician.
| Novo Nordisk Inc | $79.17 |
|---|---|
| Ascendis Pharma Endocrinology Inc | $62.76 |
| Corcept Therapeutics | $55.27 |
| Neurocrine Biosciences, Inc. | $47.74 |
| Novartis Pharmaceuticals Corporation | $44.38 |
| Bayer HealthCare Pharmaceuticals Inc. | $39.37 |
| Beta Bionics, Inc. | $35.62 |
| Globus Medical, Inc. | $33.16 |
| Food and Beverage | $656 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 8 industry-funded studies in 2025, from 6 companies. The companies reported $1,025,390 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. · Active, not recruiting · NCT06345339 - A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM
Amgen Inc. - CT-388-104 OW/OB with T2D
Genentech, Inc. - M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. - CT-388-104 OW/OB with T2D
F. Hoffmann-la Roche AG - A phase III,randomised,double blind,placebo controlled,event driven study to assess the efficacy,safety and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on renal outco…
AstraZeneca Pharmaceuticals LP - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. - Study name not reported
Novo Nordisk As
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.